Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer
Clinical trial NCT00548899 · COMPLETED
Trial details
- NCT number
- NCT00548899
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2011-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.